MEETINGS - Conference on European/FDA Regulatory Issues In Oral Inhalation and Nasal Delivery (UK) October 1999:
This article was originally published in Clinica
Management Forum will hold a conference on European/FDA Regulatory Issues In Oral Inhalation and Nasal Delivery in London on October 25-26. Topics for discussion include: changing the focus on content uniformity; the generic experience; bioavailability and bioequivalence in Europe and evolution of pharmacodynamic methods in the USA. For more information contact Management Forum in the UK. Tel: +44 0 1483 570099. Fax: +44 0 1483 536424.
You may also be interested in...
UK start-up Iceni Diagnostics has secured funding to develop its test for the live, intact SARS-CoV-2 virus and the UK government is evaluating a lateral flow device based on the technology for testing saliva samples as part of efforts to step up rapid testing in the country. See what Iceni’s CEO Rob Field said about it here.
The run-away US FDA advisory committee review of Biogen’s Alzheimer’s candidate was highly unusual. But like most things at the agency, not entirely unprecedented.
Trump Administration’s attempt to eliminate rebates in the US Medicare outpatient drug benefit program is the easiest and most certain item among the 11th hour pricing policy changes for the incoming Biden Administration to undo. But it still had a major impact on the dynamics of the drug pricing debate.